Skip to main content
Search RSC
Clinical Research Sites
Summary of Resources
Safety
Protocol Registration
Personnel Information
Protocol Information in DAIDS-ES
DAIDS Record Storage Assessment
DAIDS Financial Disclosure Forms
Informed Consent Process Information
Network & Protocol Teams
DAIDS Drug Risk Lists
Developing Protocols
Protocol Templates
Submit a Protocol
ClinicalTrials.gov
DAIDS Protocol Risk Worksheet
Trial Master File
Clinical Trials Insurance
Useful Links
DAIDS Staff
Resources
About Us
About DAIDS & RSC
News & Updates
FAQs
Events
Contact Us
Breadcrumb
Home
Clinical Research Sites
Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A)
Document Date
Wednesday, August 18, 2021
